Join
Live feed
·
NEWSReleasevia Quantisnow
Orphazyme A/S logo

Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs

ByQuantisnow·Wall Street's wire, on your screen.
ORPH· Orphazyme A/S
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORPH (Orphazyme A/S) and more on Quantisnow.